Sartorius Stedim buys BioOutsource; Mylan said to invest in Indian facilities;

> Sartorius Stedim Biotech has acquired Scotland-based BioOutsource, which offers contract testing services, including for biosimilars. Release

> Private equity firm Carlyle Group has sold its 11.29% stake in Claris Lifesciences for about $27 million. Report

> Sigma Aldrich ($SIAL) has opened an Asia-Pacific regional headquarters in Singapore. Report

> Mylan ($MYL) will invest in the expansion of its manufacturing facilities in India. Report

And Finally... After finding companies using industrial-grade ingredients in drugs, the Taiwan FDA will create an online system companies will use to record the pharmaceutical raw materials they use. Report

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.